Our goal was to ascertain the efficacy of various antidepressant treatments for acute bipolar depression.
Method
English articles that reported on the efficacy of antidepressant treatments in bipolar depression were located by computerized Medline and manual search. These studies were systematically reviewed and response rates for each treatment were computed.
Results
The available data suggest that mood stabilizers, MAOIs, cyclic antidepressants, and ECT are all effective in treating bipolar depression. All antidepressant treatments with the exception of mood stabilizers have been reported to induce a manic/hypomanic switch.
Conclusions
It is recommended that mood stabilizers may be the first step of treatment, followed by the addition of an antidepressant, especially a cyclic antidepressant. The specific symptoms profile of individual patients, such as anergic or psychotic features, may indicate more specific treatment options. ECT is an important measure for those who are pharmacotherapy-resistant or psychotic.
References
1.
American Psychiatric Association.Diagnostic and statistical manual of mental disorders.Fourth edition.Washington DC: American Psychiatric Association; 1994.
2.
GoodwinF.K., JamisonK.R.Manic-depressive illness.New York: Oxford University Press;1990.
3.
ThomasJ.Lectures on clinical psychiatry by Dr Emil Kraepelin. 2nd English ed.London: Bailliere, Tindall and Cox;1906.
4.
PenisC.A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses.Acta Psychiatr Scand1966; (194 Suppl): 1S–189S.
5.
KatzM.M., RobinE., CroughanJ.Behavioural measurement and drug response characteristics of unipolar and bipolar depression.Psychol Med1982; 12: 25–36.
6.
JoyceP.R., PaykelE.S.Predictors of drug response in depression.Arch Gen Psychiatry1989; 46: 89–99.
7.
MendelsJ., FrazerA.Intracellular lithium concentration and clinical response: towards a membrane theory of depression.J Psychiatr Res1973; 10: 9–18.
8.
GoodwinF.K., MurphyD.L., BunneyW.E.Lithium-carbonate treatment in depression and mania; a longitudinal double-blind study.Arch Gen Psychiatry1969; 21: 486–496.
9.
GreenspanK., SchildkrautJ.J., GordonE.K.Catecholamine metabolism in affective disorder-III: MHPG and other catecholamine metabolites in patients treated with lithium carbonate.J Psychiatr Res1970; 7: 171–183.
10.
GoodwinF.K., MurphyD.L., DunnerD.L.Lithium response in unipolar versus bipolar depression.Am J Psychiatry1972; 129: 44–47.
11.
NoyesRJr, DempseyG.M., BlumA.Lithium treatment of depression.Compr Psychiatry1974; 15: 187–193.
12.
BaronM., GershonE.S., RudyV.Lithium carbonate response in depression.Arch Gen Psychiatry1975; 32: 1107–1111.
13.
MendelsJ.Lithium in the treatment of depression.Am J Psychiatry1976; 133: 373–378.
14.
DonnellyE.F., GoodwinF.K., WaldmanI.N.Prediction of antidepressant responses to lithium.Am J Psychiatry1978; 135: 552–556.
15.
StokesP.E., ShamoianC.A., StallP.M.Efficacy of lithium as acute treatment of manic-depressive illness.Lancet1971; 1: 1319–1325.
16.
FieveR.R., PlatmanS.R., PlutchikR.R.The use of lithium in affective disorders: I. acute endogenous depression.Am J Psychiatry1968; 125: 487–491.
17.
PriceL.H., CharneyD.S., HeningerG.R.Variability of response to lithium augmentation in refractory depression.Am J Psychiatry1986; 143: 1387–1392.
18.
KramlingerK.G., PostR.M.The addition of lithium to carbamazepine: antidepressant efficacy in treatment-resistant depression.Arch Gen Psychiatry1989; 46: 794–800.
19.
NelsonJ.C., MazureC.M.Lithium augmentation in psychotic depression refractory to combined drug treatment.Am J Psychiatry1986; 143: 363–366.
20.
de MontignyC., CournoyerG., MorissetteR.Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression.Arch Gen Psychiatry1983; 40: 1327–1334.
21.
HeningerG.R., CharneyD.S., SternbergD.E.Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression.Arch Gen Psychiatry1983; 40: 1335–1342.
22.
22 HimmelhochJ.M., DetreT., KupferD.J.Treatment of previously intractable depressions with tranylcypromine and lithium.J Nerv Ment Dis1972; 155: 216–220.
23.
HimmelhochJ.M., FuchsC.Z., SymonsB.J.A double-blind study of tranylcypromine treatment of major anergic depression.J Nerv Ment Dis1982; 170: 628–634.
24.
HimmelhochJ.M., ThaseM.E., MallingerA.G.Tranylcypromine versus imipramine in anergic bipolar depression.Am J Psychiatry1991; 148: 910–916.
25.
ThaseM.E., MallingerA.G., McKnightD.Treatment of imipramine-resistant recurrent depression, IV: a double-blind crossover study of tranylcypromine for anergic bipolar depression.Am J Psychiatry1992; 149: 195–198.
BaumhachlU., BiziereK., FischbachR.Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.Br JPsychiatry1989; 155(6 Suppl): 78S–83S.
28.
MendelwiczJ., YoudimM.B.H.Antidepressant potentiation of 5-hydroxytryptophan by L-deprenyl in affective illness.J Affect Disord1980; 2: 137–146.
29.
PriceL.H., CharneyD.S., HeningerG.R.Efficacy of lithium-tranylcypromine treatment in refractory depression.Am J Psychiatry1985; 142: 619–623.
30.
CohnJ.B., CollinsG., AshbrookE.A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.Int Clin Psychopharmacol1989; 4: 313–322.
31.
KessellA., HoltN.F.A controlled study of a tetracyclic antidepressant-maprotiline (ludiomil).Med J Aust1975; 1: 773–776.
32.
CoppenA., WhybrowP.C., NogueraR.The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine.Arch Gen Psychiatry1972; 26: 234–241.
33.
AveryD., LubranoA.Depression treated with imipramine and ECT: the DeCarolis study reconsidered.Am J Psychiatry1979; 136: 559–562.
HaykalR.F., AkiskalH.S.Bupropion as a promising approach to rapid cycling bipolar II patients.J Clin Psychiatry1990; 51: 450–455.
40.
FogelsonD.L., BystritskyA., PasnauR.Bupropion in the treatment of bipolar disorders the same old story.J Clin Psychiatry1992; 53: 443–446.
41.
SachsG.S., LaferB., StallA.A double-blind trial of bupropion versus desipramine for bipolar depression.J Clin Psychiatry1994; 55: 391–393.
42.
AmesD., WirshingW.C., SzubaM.P.Organic mental disorders associated with bupropion in three patients.J Clin Psychiatry1992; 53: 53–55.
43.
GreenblattM., GrosserG.H., WechslerH.A comparative study of selected antidepressant medications and EST.Am J Psychiatry1962; 119: 144–153.
44.
BratfosO., HaugJ.O.Electroconvulsive therapy and antidepressant drugs in manic-depressive disease.Acta Psychiatr Scand1965; 41: 588–596.
45.
AveryD., WinokurG.The efficacy of electroconvulsive therapy and antidepressants in depression.Biol Psychiatry1977; 12: 507–523.
46.
HomanS., LachenbruchP.A., WinokurG.An efficacy study of electroconvulsive therapy and antidepressants in the treatment of primary depression.Psychol Med1982; 12: 615–624.
47.
ZorumskiC.F., RutherfordJ.L., BurkeW.J.ECT in primary and secondary depression.J Clin Psychiatry1986; 47: 298–300.
48.
BlackD.W., WinokurG., NasrallahA.The treatment of depression: electroconvulsive therapy v antidepressants: a naturalistic evaluation of 1,495 patients.Compr Psychiatry1987; 28: 169–182.
49.
StromgrenL.S.Unilateral versus bilateral electroconvulsive therapy.Acta Psychiatr Scand1973; (240 Suppl): 7S–65S.
50.
AbramsR., TaylorM.A.Unipolar and bipolar depressive illness: phenomenology and response to electroconvulsive therapy.Arch Gen Psychiatry1974; 30: 320–321.
51.
NurnbergH.G., FinkelJ.A.Carbamazepine in bipolar-depressed disorder complicated by tricyclic antidepressant switching: case report.J Clin Psychiatry1985; 46: 487–488.
52.
BallengerJ.C., PostR.M.Carbamazepine in manic-depressive illness: a new treatment.Am J Psychiatry1980; 137: 782–790.
53.
PostR.M., UhdeT.W., BallengerJ.C.Carbamazepine and its -10, 11- epoxide metabolite in plasma and CSF: relationship to antidepressant response.Arch Gen Psychiatry1983; 40: 673–676.
54.
PostR.M., UhdeT.W., Roy-ByrneP.P.Antidepressant effects of carbamazepine.Am J Psychiatry1986; 143: 29–34.
KwamieY., PersadE., StancerH.The use of carbamazepine as an adjuctive medication in the treatment of affective disorders: a clinical report.Can J Psychiatry1984; 29: 605–608.
57.
CalabreseJ.R., DelucchiG.A.Spectrum of efficacy of valproate in 55 patients with rapid cycling bipolar disorder.Am J Psychiatry1990; 147: 431–434.
58.
RushA.J., SchlesserM.A., ErmanM.Alprazolam in bipolar-I depressions.Pharmacotherapy1984; 4: 40–42.
59.
KishimotoA., KamataK., SugiharaT.Treatment of depression with clonazepam.Acta Psychiatr Scand1988; 77: 81–86.
60.
DunnerD., MyerS.J., KhanA.Adinazolam — a new antidepressant: findings of a placebo-controlled, double-blind study in outpatients with major depression.J Clin Psychopharmacol1987; 7: 170–172.
61.
MurphyD.L., BakerM., GoodwinF.K.L-tryptophan in affective disorders: indolamine changes and differential clinical effects.Psychopharmacologia (Berl)1974; 34: 11–20.
62.
FarkasT., DunnerD.L., FieveR.R.L-tryptophan in depression.Biol Psychiatry1976; 11: 295–302.
63.
MendelsJ., StinnettJ.L., BurnsD.Amine precursors and depression.Arch Gen Psychiatry1975; 32: 22–30.
64.
ChouinardG., YoungS.N., AnnableL.Tryptophan-nicotinamide, imipramine and their combination in depression.Acta Psychiatr Scand1979; 59: 395–414.
65.
PostR.M., GernerR.H., CarmanJ.S.Effects of a dopamine agonist piribedil in depressed patients; relationship of pretreatment homovanillic acid to antidepressant response.Arch Gen Psychiatry1978; 35: 609–615.
66.
SilverstoneT.Response to bromocriptine distinguishes bipolar from unipolar depression (letter).Lancet1984; 1: 903–904.
67.
BocchettaA., BernardiF., BurraiC.A double-blind study of L-sulpiride versus amitriptyline in lithmm-maintained bipolar depressives.Acta Psychiatr Scand1993; 88: 434–439.
68.
PriviteraM.R., LambertiJ.S., MaharajK.Clonazepam in a depressed patient (letter).Am J Psychiatry1993; 150: 986.
69.
PostR.M., KotinJ., GoodwinF.K.Effects of sleep deprivation on mood and central amine metabolism in depressed patients.Arch Gen Psychiatry1976; 33: 627–632.
70.
WehrT.A., Wirz-JusticeA., GoodwinF.K.Phase advance of the circadian sleep-wake cycle as an antidepressant.Science1979; 206(9): 710–713.
71.
SzubaM.P., BaxterL.R., FairbanksL.A.Effects of partial sleep deprivation on the diurnal variation of mood and motor activity in major depression.Biol Psychiatry1991; 30: 817–829.
72.
SackD.A., NurnbergerJ., RosenthalN.E.Potentiation of antidepressant medications by phase advance of the sleep-wake cycle.Am J Psychiatry1985; 142: 606–608.
73.
SouetreE., SalvatiE., PringueyD.Antidepressant effects of the sleep/wake cycle phase advance. Preliminary report.J Affect Disord1987; 12: 41–46.
74.
DeltitoJ.A., MolineM., PollakC.Effects of phototherapy on non-seasonal unipolar and bipolar depressive spectrum disorders.J Affect Disord1991; 23: 231–237.
75.
JimersonD.C., PostR.M., StoddardF.J.Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients.Biol Psychiatry1980; 15: 45–57.
76.
SimonP., LecrubierY., JouventR.Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant.Psychol Med1978; 8: 335–338.
77.
OsmanO.T., RudorferM.V., PotterW.Z.Idazoxan: a selective 2-antagonist and effective sustained antidepressant in two bipolar depressed patients [letter].Arch Gen Psychiatry1989; 46: 958–959.
78.
KasperS., MoisesH.W., BeckmannH.The anticholinergic biperiden in depressive disorders.Pharmacopsychiatry1981; 14: 195–198.
79.
CarneyM.W.P., MartinR., BottiglieriT.Switch mechanism in affective illness and s-adenosylmethionine [letter].Lancet1983; 1: 820–821.
80.
LipiskiJ.F., CohenB.M., FrankenburgF.Open trial of s-adenosylmethionine for treatment of depression.Am J Psychiatry1984; 141: 448–450.
81.
AranaG.W., ForbesR.A.Dexamethasone for the treatment of depression: a preliminary report.J Clin Psychiatry1991; 52: 304–306.
82.
KastinA.J., SchalchD.S., EhrensingR.H.Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.Lancet1972; 2: 740–742.
83.
NaylorG.J., SmithA.H.W.Vanadium: a possible etiologic factor in manic depressive illness.Psychol Med1981; 11: 249–256.
84.
KayD.S.G., NaylorG.J., SmithA.H.W.The therapeutic effect of ascorbic acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard treatments.Psychol Med1984; 14: 533–539.
85.
DeickenR.F.Verapamil treatment of bipolar depression [letter].J Clin Psychopharmacol1990; 10: 148–149.
86.
ExteinI., PickarD., GoldM.S.Methadone and morphine in depression.Psychopharmacol Bull1981; 17: 29–33.
87.
WherT.A., GoodwinF.K.Can antidepressants cause mania and worsen the course of affective illness?Am J Psychiatry1987; 144: 1403–1411.
88.
AngstJ., AngstK., BaruffolI.K.ECT-induced and drag-induced hypomania.Convulsive Ther1992; 8: 179–185.
89.
PeetM.Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.Br J Psychiatry1994; 164: 549–550.
